A Phase 1/1b Study of IAM1363 in HER2 Cancers

计划入组 383 人 · 首次发布于 2024 年 2 月 12 日

FS120 Phase 1/1b Study in Patients With Advanced Malignancies

计划入组 82 人 · 首次发布于 2020 年 12 月 1 日

Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer

计划入组 193 人 · 首次发布于 2014 年 8 月 19 日

Interferon alfa-1b

TMC-1B

ORL-1B

NHI-1

United States

Xi'an No.1 Hospital

China

ALPHA-1 FOUNDATION, INC.

United States

Immunic's IMU-856 Shows Promise in Celiac Disease Treatment by Restoring Gut Health

Syntis Bio Doses First Patient in Phase 1/1b Trial of Novel Oral Obesity Treatment SYNT-101

Corvus Pharmaceuticals Reports Promising Phase 1/1b Results for Soquelitinib in T Cell Lymphoma at ASH 2025